About Ephyla
Ephyla is an independent French biotechnology laboratory based in Arzal, Brittany. It designs naturally derived active ingredients for cosmetic and dermocosmetic applications and supports projects from resource sourcing through scientific validation and formulation. Its stated approach combines botany, biochemistry, biology, physics and biomimicry with responsible, traceable supply chains in France and international sourcing regions. Services include active-ingredient co-development, sustainable value-chain design, efficacy evaluation, application-laboratory work, environmental-impact assessment and technical documentation. Ephyla also offers available ingredients alongside custom development programs. The company presents proprietary screening tools and biological models, including an in-house endocrine-disruptor screening test, and references ecosystem-impact work through its Ecoseastem initiative. Performance, patent and impact statements are first-party claims unless supported by project-specific documentation.
Frequently asked questions
Yes. Its official FAQ states that it offers available active ingredients as well as custom co-development.
Its services can cover sourcing, value-chain planning, R&D, efficacy evidence, formulation and preparation for industrialization.
Yes. The company says it collaborates in France and internationally while adapting documentation and quality work to project requirements.
Depending on scope, it develops evaluation plans and supplies data from laboratory tests, internal models or analyses with a claim-oriented synthesis.
Ephyla says laboratory visits or technical video calls may be arranged according to project stage and confidentiality constraints.
More details about Ephyla
Laboratory profile
Ephyla is a French biotechnology laboratory focused on naturally derived active ingredients for cosmetics and dermocosmetics. The company describes an integrated model that connects field resources, scientific research, ingredient development, efficacy evidence and formulation. Its work is intended for brands, laboratories and larger industry groups seeking either available actives or a differentiated co-development program.
Responsible sourcing and value chains
Ephyla structures plant-resource value chains with local partners in France, Africa, Polynesia and other regions. Published services include resource identification, qualification, traceability systems, field practices, quality requirements and supply-chain planning. The company says this work is designed to protect biodiversity, support local communities and create durable local value. These social and environmental outcomes are company-reported and should be assessed against the documentation for each specific sourcing program.
Biomimetic research and active development
The R&D approach combines botany, biochemistry, biology, physics and observation of living systems. Ephyla offers mechanism identification, screening, active selection, scientific concept development and pilot-scale work. Its collaborative model can cover project scoping, a scientific roadmap, prototypes, pilot production and preparation for industrial scale-up. The company also reports an in-house endocrine-disruptor screening tool and access to biological models intended to anticipate efficacy or regulatory questions.
Efficacy, formulation and impact
Ephyla develops evaluation plans and organizes laboratory tests or analyses to produce data for R&D, quality and marketing teams. Its application laboratory assists with dosage, compatibility, prototypes, sensory characteristics and finished cosmetic concepts. The company says it designs claims around evidence and clearly stated study limits. Environmental considerations may be integrated at the beginning of a project through indicators, technical trade-offs and ecosystem-compatibility assessments. Coral-impact evaluation is associated with the company’s Ecoseastem initiative.
Project delivery
Technical deliverables may include traceability information, quality records, data sheets, evaluation summaries, formulation guidance and integration support. Brands without internal laboratory capabilities can outsource broad portions of sourcing, R&D, evidence generation and formulation, while established groups can engage Ephyla for specialized exploration or co-development. Prospective partners are asked to provide the desired active type, application, constraints and timeline before a scoping discussion and proposed roadmap.
Verification note
Ephyla’s website contains claims regarding patents, measured impact and project outcomes. Buyers should request current patents, test protocols, certificates, safety information and ingredient-specific technical files before relying on those claims for regulatory or marketing purposes.
Services
Novel ingredient development turns a promising new material, such as a peptide, a fermented polysaccharide or a plant cell culture extract, into a defined cosmetic ingredient. The work fixes a production route, confirms the identity and purity of each batch, measures stability and builds the technical file a formulator needs before the first trials.
Ingredient screening programmes compare candidate compounds, extracts and combinations against a defined experimental question and return a traceable shortlist. Each candidate runs under the same assay conditions, so the ranking reflects the measurement you set, whether that is a biological signal or a technical property such as solubility in a chosen base.
Cosmetic efficacy testing measures the benefit a cosmetic or active ingredient delivers. Human studies track changes in volunteers with instruments, expert grading and imaging, for outcomes such as hydration, wrinkles, radiance or sebum. Laboratory studies use cell cultures, reconstructed skin and skin explants to show how an ingredient works at the biological level, which supports mechanism claims.
Claims substantiation is the work of matching every benefit statement on a cosmetic to evidence that supports it. The work runs in three stages. Planning sets out which literature and studies each claim needs. Documentation assembles reports and references into a traceable file. Review checks pack text, adverts and social posts against that file and the rules of the target market.
Custom formula creation is the development of an original cosmetic formula from a written product brief. A cosmetic chemist chooses the ingredients, grades and percentages, designs the processing method and makes bench batches to test the result against your requirements. The project ends with an agreed formula, documented in enough detail to be reproduced, and samples of the approved version.
Cosmetic prototype development produces small trial batches of a proposed formula so that you can see, touch and apply the product. The formulator makes variants that differ in ingredient ratios or processing, collects your feedback and revises the formula in documented rounds. It finishes with one selected prototype and the record of how it was reached.
Packaging material compatibility testing looks at the pack side of the formula-pack pairing. Plastics, glass, metals, elastomers and coatings are stored in contact with the product, then inspected and measured for stress cracking, swelling, softening, corrosion, delamination, discolouration and loss of function in closures, pumps, sprayers and droppers.
Manufacturing from your formula is contract production of a cosmetic whose formula and specification you already own. The manufacturer checks that the formula runs on its equipment, buys the raw materials, makes each batch to your process, tests it against your specification and releases it with a batch record and certificate of analysis. Filling and packing can be added to the same order.
Formula specifications and manufacturing instructions turn a laboratory formula into a written technical package. The specification lists each raw material by INCI name, grade, supplier and percentage, plus finished-product limits for appearance, pH and viscosity. The manufacturing instructions set out phases, order of addition, temperatures, mixing speeds, hold times and the in-process checks for every batch.
Pilot-to-industrial scale-up is the transfer of a cosmetic manufacturing process from a laboratory or pilot batch to full-size production equipment. Process engineers adjust mixing speed, shear, heating and cooling rates, phase addition and hold times for the larger vessel, then make trial batches. The aim is a production batch with the same viscosity, appearance and stability as the approved laboratory standard.
Company gallery










